Tc-MDP uptake in bone is not well elucidated. In this study, we utilized a mouse tibia injury model, single-photon emission computed tomography (gamma scintigraphy or SPECT), ex vivo micro-computed tomography, and histology to monitor 99m Tc-MDP uptake in injury sites during skeletal healing. In an ex vivo culture system, calvarial cells were differentiated into osteoblasts with osteogenic medium, pulsed with 99m Tc-MDP at different time points, and quantitated for 99m Tc-MDP uptake with a gamma counter. We demonstrated that 99m Tc-MDP uptake in the injury sites corresponded to osteoblast generation in those sites throughout the healing process. The 99m Tc-MDP uptake within the injury sites peaked on day 7 post-injury, while the injury sites were occupied by mature osteoblasts also starting from day 7. 99m Tc-MDP uptake started to decrease 14 days post-surgery, when we observed the highest level of bony tissue in the injury sites. We also found that 99m Tc-MDP uptake was associated with osteoblast maturation and mineralization in vitro. This study provides direct and biological evidence for 99m Tc-MDP uptake in osteoblasts during bone healing in vivo and in vitro.
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INTRODUCTION
The treatment of severe bone diseases often requires invasive surgery; therefore, precise skeletal imaging is critical for efficient treatment. Tc-Methylene diphosphonate ( 99m Tc-MDP) is extensively used as an imaging agent in single-photon emission computed tomography (SPECT). [1] [2] [3] [4] [5] Though it is well known that 99m Tc-MDP accumulates in areas of active bone metabolism, the microscopic mechanism of 99m Tc-MDP-bone uptake has not been well elucidated. To date, the 99m Tc-MDP-uptake mechanism has been investigated by (1) ex vivo studies measuring the uptake of 99m Tc-MDP in synthesized bone-mimicking material, osteoblast-like cells, collagen sponges, or inorganic or organic phase of bone tissue and (2) in vivo imaging using bone-disease or bone-healing models with or without implants. The majority of previous work suggested that 99m Tc-MDP uptake was associated with mineralization, [6] [7] [8] [9] [10] [11] [12] but some investigations argued that the organic compartment was also strongly involved. [13] [14] [15] [16] [17] [18] Most studies on the accumulation of 99m Tc-MDP in bone have lacked detailed information on osteoblast status; in some cases, the bone cells were dead when isotopebinding assays were performed. Osteoblast-lineage cells express different genes and behave differently throughout their differentiation/maturation from mesenchymal stem cells to mature osteoblasts and osteocytes. 19 Osteoblasts are specialized cells that are able to secrete and mineralize the extracellular matrix (ECM), which is mainly composed of type I collagen along with smaller but significant, amounts of other proteins, including osteocalcin (Ocn). Once osteoblasts are embedded into bone matrix, they are defined as osteocytes. In response to skeletal injury, mesenchymal cells from the periosteum (a thin layer covering the bone outer surface) or other surrounding tissues invade the wound site, proliferate, condense, differentiate into chondrocytes or osteoblasts, and mineralize. 20 This study investigated the accumulation of 99m
Tc-MDP in bone in the context of osteoblast differentiation, using a skeletal injury model and a well-established reporter mouse model (Ocn-Cre;mT/mG) to mark mature osteoblasts. Skeletal-injury surgery The detailed procedure was described previously. 23 Briefly, three-month-old female Ocn-Cre;mT/mG mice were anesthetized with intraperitoneal injection of avertin. A 5-mm incision was made over the anteriorproximal tibia, and the tibial surface was exposed while carefully preserving the periosteum. A 1.0-mm hole was drilled through the anterior cortex with a high-speed dental drill. Wounds were closed with size 6-0 vicryl sutures. After surgery, mice received subcutaneous injections of tramadol for analgesia and were allowed to ambulate freely. Mice were scanned with SPECT/CT at indicated times post-surgery.
METHODS

Ethics
99m Tc-MDP SPECT/CT Mice were placed in a 37.5 6 C-heated cage 20-30 minutes prior to radiotracer injection and moved to a 37.5 6 C-heated induction chamber 10 minutes prior to injection, where they were anesthetized with 2% isoflurane in 1000 cc?min 21 oxygen. A dose of 1 mCi in 0.1 mL of 99m Tc-MDP was administered by tail vein injection and the mice were placed in a 37.5 6 C-heated cage for 60 minutes of conscious uptake. SPECT/CT scans were acquired using a Bioscan NanoSPECT/CT (Washington, DC) with fixtures to maintain heat and anesthesia throughout the process. Mice were imaged via a 24-minute static acquisition for SPECT imaging followed immediately by a 3-minute CT acquisition. SPECT reconstruction was performed using a dedicated Ordered Subset-Expectation Maximization algorithm and CT reconstruction used Filtered Back Projection with a Shepp-Logan Filter. Fused SPECT/CT images were analyzed using VivoQuant Image Analysis Suite (inviCRO, LLC, Boston, MA). The following standard operating procedures (SOP) were used: SOP 6.046 (SPECT imaging of mice); SOP 6.048 (CT imaging of mice).
Osteoblast primary culture Calvarial cells were isolated from calvariae of newborn mice by serial digestion in 0.2 mg?mL 21 collagenase type I (Worthington, Lakewood, NJ). Briefly, calvariae were digested for 15 minutes at 37 6 C with constant agitation. The digestion solution was collected and digested for additional five times. Digestions 3-6 (containing the osteoblasts) were centrifuged, washed with a-MEM containing 10% fetal bovine serum and 1% penicillin/streptomycin, and cultured for 48 hours at 37 6 C. 20 The same numbers of calvarial cells were cultured in 35-mm dishes and differentiated into osteoblasts with osteogenic media (change every 2 days) containing 50 mg?mL 21 ascorbic acid and 10 mmol?L -1 b-glycerol phosphate (bGP).
In-vitro 99m Tc-MDP analysis
The osteoblasts in 35-mm dishes (three plates for each group) were incubated in 100 mL of 0.9% saline diluted Tc-MDP (3.7 mBq) for exact 40 minutes at 37 6 C and 5% CO 2 atmosphere. The medium was aspirated, and then the dish was twice washed gently with 0.45 mL ice-cold 0.9% saline. The cells in each dish were digested with 0.2 mL 1X trypsin-EDTA for 15 minutes. The suspension of cell clusters was pipetted cautiously. The dishes were further washed twice with 0.9 mL of 0.9% saline. The cell suspension was combined with the washing saline. The residual mineral component in dish was washed with 2 mL 100 mmol?L 21 HCl for 15 minutes and the solution was collected. Planar gamma camera images were acquired for the dishes before and after aspirating the medium, and also following the cell removal and acid washing steps, respectively. A 99m Tc standard was measured simultaneously with the samples. Immunohistochemistry and staining Bone tissue samples were fixed in 4% paraformaldehyde overnight and decalcified in 10% EDTA for 10 days. Tissues were paraffin-embedded, and 7-mm sections were adhered to glass slides. Anti-GFP IHC was performed with Ventana Discovery Ultra (Tucson, AR). TRAP staining was performed using a leukocyte acid phosphate kit (Sigma) with fast red violet.
Quantitative real-time RT-PCR analysis Total RNA was extracted from cells using RNeasy (Qiagen). The extracted RNA was used for cDNA synthesis via reverse transcriptase using Superscript III and random primers (Invitrogen). The cDNA samples were subjected to PCR analysis using Taqman PCR Master Mix and 320 mouse axin2 primer and probes (Applied Biosystems). Amplifications were then performed on an ABI 7500 Real-time PCR system. The expression of the gene of interest and the housekeeping gene (18S ribosomal RNA) were simultaneously determined in the same sample. For each sample, mRNA levels for each gene were normalized to 18S ribosomal RNA levels.
Statistical analyses
Results are presented as mean 6 SD, with n equal to the number of samples analyzed. Student's t-test was used to test for significant differences between data sets.
Significance was defined as P,0.05, and all statistical analyses were performed with Microsoft Excel.
RESULTS
Skeletal injury model
To study the relationship between osteoblast maturation and 99m Tc-MDP uptake at injury sites during bone healing, we used a mouse reporter strain (Ocn-Cre;mT/mG) that possesses both Cre recombinase driven by an osteoblast-specific osteocalcin promoter (Ocn-Cre) and a reporter transgene mT/mG (Figure 1a ). Ocn-Cre;mT/mG mice express green fluorescent protein (GFP) in mature osteoblasts and osteocytes. 22, 24 We traced osteoblast differentiation by using immunohistochemical (IHC) analysis with anti-GFP antibody in dissected bone tissue (Figure 1b ). For the skeletal injury model, a 1-mm hole was made in the proximal tibia with a dental drill (Figure 1c ). At the indicated time points post-surgery, the animals were evaluated by SPECT/computed tomography (CT) scan 1 hour after intravenous 99m
Tc-MDP injections. The tibia samples were collected from 3 to 5 mice at each time point for an ex vivo micro-computed tomography (micro-CT) scan (Figure 1c ) and histological analysis (Figure 1d ). MDP uptake in bone healing ZA Zhong et al. 4
to form at the periosteum and endosteum adjacent to the injury sites 7 days post-surgery. Significant mineralized mass was present inside the injury sites 14 days post-surgery (Figure 2a) . We then decalcified the tibia samples and stained the paraffin sections with pentachrome. Corresponding to the micro-CT data, we found bony tissue began to form in the cavity and cells populated the injury sites 7 days post-surgery (Figure 2b) . We observed bony tissue filling the injury sites (Figure 2b) , and tartrate-resistant acid phosphatase (TRAP) staining (associated with osteoclast activity) reached the highest level in the injury sites on day 14 post-surgery ( Figure S1 ). These observations suggested that histologic data correlated well with the X-ray photographic data in monitoring bone healing.
Next we measured 99m
Tc-MDP uptake during bone healing. At each time point, we injected the injured mice with 99m Tc-MDP and visualized isotope intensity in the injury sites by SPECT/CT scanning (Figure 3a) . The relative isotope intensity in the injury site was normalized with the other intact tibia of the same animal. Although there was little mineralization noted in the injury sites 4 days post-surgery by micro-CT or histology (Figure 2a and b) , we observed threefold higher 99m Tc-MDP uptake on day 4 compared with day 0 (Figure 3b) . The 99m Tc-MDP uptake in the injury sites was highest on day 7 post-surgery, and decreased 14 and 21 days post-surgery (Figure 3b) . The 99m Tc-MDP-uptake dynamics in individual injured animals showed similar patterns (Figure 3c ). To determine how 99m
Tc-MDP-uptake dynamics correlate with osteoblast generation, we performed IHC analysis with anti-GFP antibody to identify mature osteoblasts. First, we focused on tissues adjacent to the injury sites. We found that the mature osteoblast population within the periosteal region increased robustly 7 days post-surgery, and chondrogenesis increased significantly on day 14 post-injury (Figure 4a ). At the injury sites, the number of mature osteoblasts was increased at the cortical bone surface 4 days post-surgery (Figure 4b . There was high density of cells at the injury sites with a significant portion being mature osteoblasts, which were apparent on day 7, and by 14 days MDP uptake in bone healing ZA Zhong et al. 5
after surgery, most of the cells were mature osteoblasts (Figure 4b ).
99m Tc-MDP uptake correlates to osteoblast differentiation and mineralization in vitro We next isolated primary calvarial cells from 3-day-old Ocn-Cre;mT/mG neonates and differentiated the cells into osteoblasts with osteogenic medium. Using a fluorescent microscope, we observed that calvarial cells were differentiating into GFP1 mature osteoblasts (Figure 5a ), which was confirmed by real-time PCR of Ocn expression (Figure 5b ). The calvarial cells were pulsed with Tc-MDP correlated with osteoblast maturation both in the cell fraction and in residual mineral fraction ( Figure S2 ). We detected a small amount of calcium (by Alizarin red staining) and phosphate (by Von Kossa staining) in calvarial cells after 14 days of differentiation, and much higher levels of calcium and phosphate after 21 days of differentiation ( Figure S3 ).
DISCUSSION
In this work, we investigated the accumulation of Tc-MDP uptake correlates with both osteoblast differentiation and mineralization. One caveat to note is that 99m Tc-MDP uptake itself might have affected the bone repair process, which was not evaluated in the current study. The Tc-MDP uptake dynamics we observed in our skeletal injury model was similar to that found in previous studies on intraosseous implants, which showed that 99m Tc-MDP uptake occurred mostly during active bone formation and mineralization 7-10 days post-surgery in rats. 13, 25 A previous fracture-healing study showed that Ocn mRNA (as a mature osteoblast marker) increased from day 10, and peaked on day 15 post-fracture. 26 We observed a similar MDP uptake in bone healing ZA Zhong et al. 6
pattern of Ocn activation at protein level using the OcnCre;mT/mG model, in which Ocn is represented by GFP expression driven by the Ocn promoter (Figure 4b) .
The nature of MDP phosphate has been generally neglected in bone-seeker research; it might be actively transported by cells, including osteoblasts. Evidence has shown that phosphate is a specific signal that modulates osteoblast differentiation by regulating protein function and gene expression. 23, [27] [28] Osteoblasts actively gather phosphate through transporter mechanisms, which is important for primary calcification of the bone matrix. [29] [30] [31] Recent studies using transmission electron microscopy verified the presence of nano-sized calcium phosphate within osteoblast mitochondrial granules and intracellular vesicles, suggesting that the storage and transport of such mineralcontaining vesicles may play important roles in mediating bone mineralization. [32] [33] Such evidence supports the possibility that 99m Tc-MDP can also be captured and transported by osteoblasts through phosphate transporter/vesicles. In fact, bisphosphonates have direct biological functions on osteoblasts, in addition to previous recognition that they can affect the solubility of hydroxyapatite after being adsorbed.
34-37
The 99m Tc-MDP-uptake mechanism involving osteoblast differentiation that we proposed addresses the consideration of a balanced assessment of bone seeker uptake by organic and non-organic tissues. It will be informative for understanding the microscopic location of 99m Tc-MDP under physiological and pathological conditions.
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